Lori Coward

4.5k total citations · 1 hit paper
44 papers, 3.6k citations indexed

About

Lori Coward is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Lori Coward has authored 44 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 14 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Lori Coward's work include Phytoestrogen effects and research (15 papers), Diet, Metabolism, and Disease (5 papers) and Estrogen and related hormone effects (4 papers). Lori Coward is often cited by papers focused on Phytoestrogen effects and research (15 papers), Diet, Metabolism, and Disease (5 papers) and Estrogen and related hormone effects (4 papers). Lori Coward collaborates with scholars based in United States, Malaysia and Denmark. Lori Coward's co-authors include Stephen Barnes, Marion Kirk, Kenneth D.R. Setchell, Michelle Smith, T. Greg Peterson, Stephanie L. Barnes, Nicolas Albin, Victor Darley‐Usmar, Martyn Kirk and Pamela L. Horn‐Ross and has published in prestigious journals such as Journal of Biological Chemistry, American Journal of Clinical Nutrition and Cancer Research.

In The Last Decade

Lori Coward

42 papers receiving 3.4k citations

Hit Papers

Genistein, daidzein, and their .beta.-glycoside conjugate... 1993 2026 2004 2015 1993 200 400 600

Peers

Lori Coward
Laurie J. Custer United States
T. Fotsis Finland
H L Newmark United States
Kimberly F. Allred United States
Barbara Simi United States
Laurie J. Custer United States
Lori Coward
Citations per year, relative to Lori Coward Lori Coward (= 1×) peers Laurie J. Custer

Countries citing papers authored by Lori Coward

Since Specialization
Citations

This map shows the geographic impact of Lori Coward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Coward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Coward more than expected).

Fields of papers citing papers by Lori Coward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Coward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Coward. The network helps show where Lori Coward may publish in the future.

Co-authorship network of co-authors of Lori Coward

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Coward. A scholar is included among the top collaborators of Lori Coward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Coward. Lori Coward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coward, Lori, et al.. (2023). Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome. Drug and Alcohol Dependence. 249. 110832–110832. 2 indexed citations
2.
Gorman, Gregory S., Lori Coward, Konstantin Christov, et al.. (2023). The brain-penetrant cell-cycle inhibitor p28 sensitizes brain metastases to DNA-damaging agents. Neuro-Oncology Advances. 5(1). vdad042–vdad042. 5 indexed citations
3.
Coward, Lori, et al.. (2022). In vitro metabolic biomodulation of irinotecan to increase potency and reduce dose-limiting toxicity by inhibition of SN-38 glucuronide formation. Drug Metabolism and Personalized Therapy. 37(3). 295–303. 2 indexed citations
4.
Coward, Lori, et al.. (2016). Small Molecules Revealed in a Screen Targeting Epithelial Scattering Are Inhibitors of Microtubule Polymerization. SLAS DISCOVERY. 21(7). 671–679. 2 indexed citations
5.
Cruthirds, Danielle L., et al.. (2015). Incorporation of Hands-On Sterile Technique Instruction in an Introductory Pharmacy Practice Experience. American Journal of Pharmaceutical Education. 79(2). 28–28. 11 indexed citations
6.
Coward, Lori, et al.. (2014). In vitro inhibitory effects of herbal supplements on tamoxifen and irinotecan metabolism. Drug metabolism and drug interactions. 29(4). 269–279. 3 indexed citations
7.
Gorman, Greg, et al.. (2010). A novel and rapid LC/MS/MS assay for bioanalysis of Azurin p28 in serum and its pharmacokinetics in mice. Journal of Pharmaceutical and Biomedical Analysis. 53(4). 991–996. 12 indexed citations
8.
Jia, Lee, Gregory S. Gorman, Lori Coward, et al.. (2010). Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination. Cancer Chemotherapy and Pharmacology. 68(2). 513–524. 56 indexed citations
9.
Jia, Lee, Patricia E. Noker, Gary A. Piazza, et al.. (2008). Pharmacokinetics and pharmacodynamics of Phor21-βCG(ala), a lytic peptide conjugate. Journal of Pharmacy and Pharmacology. 60(11). 1441–1448. 11 indexed citations
10.
Aslan, Mutay, Thomas M. Ryan, Tim M. Townes, et al.. (2003). Nitric Oxide-dependent Generation of Reactive Species in Sickle Cell Disease. Journal of Biological Chemistry. 278(6). 4194–4204. 141 indexed citations
11.
Brookes, Paul S., Anita Pinner, Anup Ramachandran, et al.. (2002). High throughput two-dimensional blue-native electrophoresis: A tool for functional proteomics of mitochondria and signaling complexes. PROTEOMICS. 2(8). 969–969. 129 indexed citations
12.
Barnes, Stephen, et al.. (2002). HPLC-Mass Spectrometry of Isoflavonoids in Soy and the American Groundnut, Apios Americana. Advances in experimental medicine and biology. 505. 77–88. 14 indexed citations
13.
Novák, Jan, Milan Tomana, Mogens Kilian, et al.. (2000). Heterogeneity of O-glycosylation in the hinge region of human IgA1. Molecular Immunology. 37(17). 1047–1056. 60 indexed citations
14.
Kirk, Marion, et al.. (2000). p-Cresol Sulfate Is the Dominant Component of Urinary Myelin Basic Protein Like Material. Archives of Biochemistry and Biophysics. 377(1). 9–21. 22 indexed citations
15.
Coward, Lori, et al.. (1998). Chemical modification of isoflavones in soyfoods during cooking and processing. American Journal of Clinical Nutrition. 68(6). 1486S–1491S. 289 indexed citations
16.
Barnes, Stephanie L., et al.. (1998). HPLC-Mass Spectrometry Analysis of Isoflavones. Experimental Biology and Medicine. 217(3). 254–262. 108 indexed citations
17.
Coward, Lori, Marion Kirk, Nicolas Albin, & Stephen Barnes. (1996). Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clinica Chimica Acta. 247(1-2). 121–142. 162 indexed citations
18.
Peterson, T. Greg, Lori Coward, Marion Kirk, Charles N. Falany, & Stephen Barnes. (1996). The role of metabolism in mammary epithelial cell growth inhibitionby the isoflavones genistein and biochanin A. Carcinogenesis. 17(9). 1861–1869. 80 indexed citations
19.
Barnes, Stephen, T. Greg Peterson, & Lori Coward. (1995). Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. Journal of Cellular Biochemistry. 59(S22). 181–187. 209 indexed citations
20.
Falany, Charles N., et al.. (1992). Bioactivation of 7‐hydroxymethyl‐12‐ methyibenz[a]anthracene by rat liver bile acid sulfotransferase I. Journal of Biochemical Toxicology. 7(4). 241–248. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026